LN-144
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LN-144, covering 2025-06-05 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma [Phase 1]